Company intelligence
As of August 4, 2026, QuantHealth has raised at least $45M in equity across 1 sourced funding round.
QuantHealth is a Tel Aviv-based company whose software simulates clinical trials before patients are enrolled.[1] Drug developers use it to test protocols, refine inclusion and exclusion criteria and model commercial outcomes in silico.[1] The company says it has simulated more than 600 trials with up to 90% predictive accuracy.[1] It works with 12 of the world's top 20 pharmaceutical companies across oncology, cardiometabolic and inflammatory diseases.[1] Sanofi Ventures, Pitango HealthTech, Bertelsmann Healthcare Investments, Artofin, GC Ventures, NewHealth, Shoni Top and Esplanade Ventures also took part.[1] The money will fund new models, scientific validation, coverage beyond 40 indications and new products across the clinical and commercial lifecycle.[1]
Is this your company? Get featured or correct your listing →
| Date | Round | Amount | Valuation | Lead investors | Source |
|---|---|---|---|---|---|
| Aug 4, 2026 | Series B | $45M | — | HIT ConsultantPulse story |
Equity only. “Equity raised” above sums the rounds with a dated, linked source; rumored rounds, tender offers and secondary sales are listed but not counted, and debt financing is listed separately.
In August 2026 QuantHealth closed a $45 million Series B led by Qumra Capital.[1]
QuantHealth raised a $45M Series B led by Qumra Capital to expand AI simulation of clinical trials before patients enroll, a platform already used by 12 of the world's top 20 pharma companies.
Qumra Capital led a $45M Series B for QuantHealth, which builds AI simulations of clinical trials so drug developers can test protocol designs before enrolling a single patient.
In August 2026 QuantHealth closed a $45 million Series B led by Qumra Capital.[1]
QuantHealth was founded in 2020; Orr Inbar is co-founder and CEO and Arnon Horev is co-founder and chief strategy and operations officer.[2]
QuantHealth is a Tel Aviv-based company whose software simulates clinical trials before patients are enrolled.[1]
QuantHealth has raised at least $45M in equity across 1 sourced funding round tracked by Value Add VC. The most recent was a $45M Series B in August 2026, reported by HIT Consultant. Debt financing, tender offers and secondary sales are not counted.
QuantHealth was founded in 2020 and is headquartered in Tel Aviv, Israel, according to QuantHealth (official site, About Us) and HIT Consultant.
Figures are labelled Reported (a source states it), Estimated, Derived (computed from other facts) or Rumored (in talks / unconfirmed). Rumors never replace a confirmed figure. Each figure keeps its own as-of date; history is preserved rather than overwritten.